Stephanie L. Lee, MD, PhD

Professor, Medicine

Stephanie Lee
617.638.8530
720 Harrison Avenue (DOB-Doctors Office Building)

Biography

Stephanie L. Lee, Ph.D., M.D., F.A.C.E., E.C.N.U graduated from UC San Diego with a MD and PhD in Physiology and Pharmacology and completed a molecular and clinical fellowship in Endocrinology. Her research interests are to improve the methods to diagnosis and manage thyroid cancer.

Other Positions

  • Member, BU-BMC Cancer Center, Boston University
  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University

Education

  • University of California, San Diego, MD
  • University of California, San Diego, PhD
  • University of California, Santa Barbara, BA

Publications

  • Published on 10/1/2020

    Goundan PN, Lee SL. Thyroid effects of amiodarone: clinical update. Curr Opin Endocrinol Diabetes Obes. 2020 Oct; 27(5):329-334. PMID: 32773570.

    Read at: PubMed
  • Published on 7/23/2020

    Chung R, Guan H, Ponchiardi C, Cerda S, Marwaha N, Yilmaz OH, Pinjic E, McAneny D, Lee SL, Drake FT. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: Epidemiology and Long-Term Outcomes in a Strictly Defined Cohort. Thyroid. 2020 Jul 23. PMID: 32539676.

    Read at: PubMed
  • Published on 6/19/2020

    Fazeli SR, Zehr B, Amraei R, Toraldo G, Guan H, Kindelberger D, Lee S, Cerda S. ThyroSeq v2 Testing: Impact on Cytologic Diagnosis, Management, and Cost of Care in Patients with Thyroid Nodule. Thyroid. 2020 Jun 19. PMID: 32349630.

    Read at: PubMed
  • Published on 2/20/2020

    Guan H, Toraldo G, Cerda S, Godley FA, Rao SR, McAneny D, Doherty G, Braverman L, Lee SL. Utilities of RAS Mutations in Preoperative Fine Needle Biopsies for Decision Making for Thyroid Nodule Management: Results from a Single-Center Prospective Cohort. Thyroid. 2020 04; 30(4):536-547. PMID: 31996097.

    Read at: PubMed
  • Published on 8/14/2019

    Goundan PN, Lee SL. LACK OF A THRESHOLD SIZE FOR AUTONOMOUSLY FUNCTIONING THYROID NODULES THAT EXCLUDES HYPERTHYROIDISM. Endocr Pract. 2019 Dec; 25(12):1263-1267. PMID: 31412235.

    Read at: PubMed
  • Published on 9/25/2018

    Guan H, Matonis D, Toraldo G, Lee SL. Clinical Significance of Thyroid-Stimulating Hormone Receptor Gene Mutations and/or Sodium-Iodine Symporter Gene Overexpression in Indeterminate Thyroid Fine Needle Biopsies. Front Endocrinol (Lausanne). 2018; 9:566. PMID: 30319546.

    Read at: PubMed
  • Published on 1/4/2018

    Hanna GJ, Busaidy NL, Chau NG, Wirth LJ, Barletta JA, Calles A, Haddad RI, Kraft S, Cabanillas ME, Rabinowits G, O'Neill A, Limaye SA, Alexander EK, Moore FD, Misiwkeiwicz K, Thomas T, Nehs M, Marqusee E, Lee SL, Jänne PA, Lorch JH. Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study. Clin Cancer Res. 2018 04 01; 24(7):1546-1553. PMID: 29301825.

    Read at: PubMed
  • Published on 9/1/2017

    White PS, Pudusseri A, Lee SL, Eton O. Intermittent Dosing of Dabrafenib and Trametinib in Metastatic BRAFV600E Mutated Papillary Thyroid Cancer: Two Case Reports. Thyroid. 2017 Sep; 27(9):1201-1205. PMID: 28805135.

    Read at: PubMed
  • Published on 4/14/2016

    Likhterov I, Tuttle RM, Haser GC, Su HK, Bergman D, Alon EE, Bernet V, Brett E, Cobin R, Dewey EH, Doherty G, Dos Reis LL, Klopper J, Lee SL, Lupo MA, Machac J, Mechanick JI, Milas M, Orloff L, Randolph G, Ross DS, Rowe ME, Smallridge R, Terris D, Tufano RP, Urken ML. Improving the adoption of thyroid cancer clinical practice guidelines. Laryngoscope. 2016 Nov; 126(11):2640-2645. PMID: 27074952.

    Read at: PubMed
  • Published on 2/9/2016

    Pearce EN, Lee SL, Weiss R, Magner J, Garber JR, Campion FX, Leung AM. Unique obstacles to establishing thyroid cancer registries. J Clin Transl Endocrinol. 2016 Mar; 3:12-13. PMID: 29159122.

    Read at: PubMed

View 56 more publications: View full profile at BUMC

View all profiles